Table 2 Patients’ background
Variables | Total | Low NLR (<3.37, n = 36) | High NLR (≥3.37, n = 12) | p value |
|---|---|---|---|---|
Age (yr) | 70.5 (71.33 ± 6.92) | 70 (70.7 ± 7.2) | 73.5 (73.3 ± 5.9) | 0.234 |
iPSA (ng/mL) | 82.2 (605.1 ± 1446.3) | 82.2 (436.2 ± 1090.7) | 102.1 (1111.7 ± 2186.0) | 0.322 |
Pathological Grade | ||||
Gleason’s Sum ≤ 6 | 2 (4.2 %) | 1 (2.8 %) | 1 (8.3 %) | 0.156 |
Gleason’s Sum = 7 | 14 (29.2 %) | 13 (36.1 %) | 1 (8.3 %) | |
Gleason’s Sum ≥ 8 | 32 (66.7 %) | 22 (61.1 %) | 10 (83.3 %) | |
Clinical T Stage | ||||
2 | 6 (12.5 %) | 4 (11.1 %) | 2 (16.7 %) | 0.501 |
3 | 27 (56.3 %) | 22 (61.1 %) | 5 (41.7 %) | |
4 | 15 (31.3 %) | 10 (27.8 %) | 5 (41.7 %) | |
Clinical N Stage | ||||
0 | 21 (43.8 %) | 16 (44.4 %) | 5 (41.7 %) | 0.867 |
1 | 27 (56.3 %) | 20 (55.6 %) | 7 (58.3 %) | |
Clinical M Stage | ||||
0 | 13 (27.1 %) | 12 (33.3 %) | 1 (8.3 %) | 0.091 |
1 | 35 (72.9 %) | 24 (66.7 %) | 11 (91.7 %) | |
NLR | 2.49 (2.93 ± 1.66) | 2.17 (2.25 ± 0.64) | 4.26 (4.98 ± 2.08) | <0.001 |